Hypertension Trial, Recruiting NCT06861309 Sponsor: Carilion Clinic Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06861309
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 45 years at the time of screening
  • People carrying a single baby (not twins or more) with no known physical abnormalities or suspected genetic conditions
  • People whose pregnancy does not show signs of the baby growing too slowly (for the Normal Fetal Weight arm), or whose pregnancy has been diagnosed with the baby growing too slowly — meaning the baby's estimated weight or belly measurement is below the 10th percentile (for the Fetal Growth Restriction arm)
  • People whose chromosome screening results (if done) showed a low risk for abnormalities
  • People who have already had a standard anatomy ultrasound scan during their pregnancy
  • People who plan to give birth at Carilion Roanoke Memorial Hospital or Carilion New River Valley Medical Center
  • People who are able to give informed consent to participate

Who may not be able to join:

  • People carrying more than one baby (such as twins or triplets)
  • People whose baby has a known physical abnormality that affects how the baby's size is measured on ultrasound
  • People whose baby is suspected of having a genetic disorder
  • People whose baby is suspected of having an infection
  • People who do not speak English or Spanish
  • People with unstable housing or transportation difficulties
  • People whom the trial investigators determine to be unsuitable for the study for any other clinical reason (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Megan D Whitham, MD, Carilion Clinic

Phone: 540-985-9985

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Carilion Clinic
Registry
ClinicalTrials.gov
Start date
23 April 2025
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of spiral arteries detected by ultrasound; Velocity of spiral artery jets detected by ultrasound; Speed of sound detected by Quantitative Ultrasound

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov